Wnt signaling pathway

News and Video Search Results

News coverage

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis

GlobeNewswire 03 Apr 2024

In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and..

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
GlobeNewswire 01 Apr 2024
Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
GlobeNewswire 01 Apr 2024
Research Offers Hope For Preventing Post-COVID ‘Brain Fog’ By Targeting Brain’s Blood Vessels
Eurasia Review 24 Mar 2024
Surrozen Provides Corporate Update on Clinical Programs
GlobeNewswire 18 Jan 2024

0 shares 1 views

You might like

Wnt signaling pathway media coverage

VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo

GlobeNewswire 10 Jan 2024

· VYN201 demonstrated positive effect on key biomarkers relevant to vitiligo
· Data supports VYN201’s rapid onset of..

Allarity’s Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP® Companion Diagnostic
GlobeNewswire 05 Dec 2023
Cytovation Reports Promising Interim Results from Phase 1/2a CICILIA Study with CyPep-1 in Solid Tumors
GlobeNewswire 11 Oct 2023
Can-Fite Novel Approach for the Treatment of Pancreatic Carcinoma with Namodenoson Receives Appreciation of the American Association of Cancer Research (AACR)
Business Wire 27 Sep 2023
Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke
GlobeNewswire 05 Jun 2023

Advertisement

More coverage

Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress

GlobeNewswire 22 Mar 2023

Enrolled first patient in SZN-043 Ph 1a clinical trial in chronic liver disease with data expected by the end of 2023Expect to..

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
GlobeNewswire 13 Mar 2023
DelveInsight Highlights Major Advances, Transformative Therapies, and 15+ Leading Players Wheeling the Degenerative Disc Disease Pipeline Landscape
GlobeNewswire 20 Feb 2023
VYNE Therapeutics Announces First Subjects Dosed in Phase 1a/b Clinical Trial Evaluating Pan-BET Inhibitor, VYN201, for the Treatment of Vitiligo
GlobeNewswire 17 Nov 2022
Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 4th Symposium of the Canadian Society for Virology
GlobeNewswire 08 Jun 2022